• Trendlyne logo
  • Markets
  • Alerts
  • F&O
  • MF
  • Reports
  • Screeners
  • Subscribe
  • Superstars
  • Portfolio
  • Watchlist
  • Insider Trades
  • Results
  • Data Downloader
  • Events Calendar
  • What's New
  • Explore
  • FAQs
  • Widgets
More
    Search stocks
    IND USA
    IND
    IND
    IND
    USA
    • Stocks
    • Futures & Options
    • Mutual Funds
    • News
    • Fundamentals
    • Reports
    • Corporate Actions
    • Alerts
    • Shareholding
    logo
    Cipla Ltd.
    16 Jul 2025
    1518.00
    -1.30%
    Cipla at 90, to provide quality, affordable products, says YK Hamied
    Business Line
    Respiratory and Obesity products, among focus areas reiterated by top management
    Copy LinkShare onShare on Share on Share on
    Cipla Ltd. has an average target of 1702.60 from 10 brokers.
    logo
    Sanofi Consumer Healthcare India Ltd.
    16 Jul 2025
    4931.00
    -1.49%
    Emcure enters distribution agreement with Sanofi for diabetes drugs
    Business Standard
    Emcure to distribute and promote Sanofi's oral anti-diabetic brands Amaryl and Cetapin in India, expanding access amid rising prevalence of uncontrolled diabetes
    Copy LinkShare onShare on Share on Share on
    Sanofi Consumer Healthcare India Ltd. average weekly volume is high.
    logo
    Shilpa Medicare Ltd.
    16 Jul 2025
    Drug Approval
    793.15
    -2.36%
    Why did Shilpa Medicare share jump 5% in trade today? top details here
    Business Standard
    Shilpa Medicare share price gained in trade after the company announced a positive regulatory update from the US health regulator, United States Food and Drug Administration (USFDA).
    Copy LinkShare onShare on Share on Share on
    Shilpa Medicare Ltd. is trading at high day volume of 192.3K.
    logo
    Torrent Pharmaceuticals Ltd.
    16 Jul 2025
    Regulatory Approval
    3575.50
    -1.08%
    Mid-Cap Stocks To Buy, Sell Or Hold: Torrent Pharma, One97 CommunicationsCheck Target Price
    Mid-Cap Stocks To Buy, Sell Or Hold: Torrent Pharma, One97 CommunicationsCheck Target Price
    NDTV Profit
    Mid-Cap Stocks To Buy, Sell Or Hold: Kush Bohra top picks for July 16 are Torrent Pharma and One97 Communications Ltd.
    Copy LinkShare onShare on Share on Share on
    Number of FII/FPI investors increased from 913 to 923 in Jun 2025 qtr.
    logo
    Biocon Ltd.
    16 Jul 2025
    356.85
    -0.59%
    Biocon shares jump 3% after USFDA approval for diabetes insulin drug
    Business Standard
    At 09:30 AM, Biocon shares were trading at 398.15, up by 1.97 per cent on the National Stock Exchange.
    Copy LinkShare onShare on Share on Share on
    Biocon Ltd. is trading below its 30 day SMA of 360.1
    logo
    Sun Pharmaceutical Industries Ltd.
    15 Jul 2025
    Sun Pharma gains on US launch of Leqselvi, analysts see strong upside
    Business Standard
    Sun Pharma rises 2.7% as it launches Leqselvi in US following settlement with Incyte, with analysts projecting $200-300 million revenue from the drug in 3-5 years
    Copy LinkShare onShare on Share on Share on
    Sun Pharmaceutical Industries Ltd. is trading above its 30 day SMA of 1614.3
    Sun Pharma shares rise 2% on US launch of hair loss drug after settlement
    Business Standard | 15 Jul 2025 3 more
    Sun Pharma, Incyte settle Leqselvi lawsuit; launches alopecia drug in US
    Business Line | 14 Jul 2025
    Sun Pharma launches Leqselvi in US after patent settlement with Incyte Corp
    Business Standard | 14 Jul 2025
    Sun Pharma launches hair loss drug Leqselvi in US after patent settlement
    Business Standard | 14 Jul 2025
    logo
    Wockhardt Ltd.
    15 Jul 2025
    1484.00
    -0.41%
    Wockhardt To Focus On Drug Discovery And Biologics: Chairman Khorakiwala On Exiting US Generics Business
    Wockhardt To Focus On Drug Discovery And Biologics: Chairman Khorakiwala On Exiting US Generics Business
    NDTV Profit
    The leading pharma company's US generics business incurred a loss of $8 million in FY25.
    Copy LinkShare onShare on Share on Share on
    Promoters unpledged 2.60% of shares in last quarter. Total pledge stands at 15.64% of promoter holdings
    logo
    AstraZeneca Pharma India Ltd.
    14 Jul 2025
    8915.00
    1.21%
    AstraZeneca Pharma Gets CDSCO Nod For Import, Sale Of Bladder Cancer Drug
    AstraZeneca Pharma Gets CDSCO Nod For Import, Sale Of Bladder Cancer Drug
    NDTV Profit
    The receipt of this permission paves way for the marketing of Durvalumab Solution.
    Copy LinkShare onShare on Share on Share on
    AstraZeneca Pharma India Ltd. is trading above all available SMAs
    logo
    Anthem Biosciences Ltd.
    14 Jul 2025
    811.40
    -1.14%
    Anthem Biosciences IPO subscribed 73 pc on Day 1 of offer
    Business Standard
    The initial public offer of Anthem Biosciences Ltd got subscribed 73 per cent on the first day of share sale on Monday. The initial share sale received bids for 3,21,13,406 shares against 4,40,70,682 shares on offer, according to NSE data. Non-institutional Investors category garnered 1.55 times subscription, while the quota for Retail Individual Investors (RIIs) got subscribed 58 per cent. The portion for Qualified Institutional Buyers (QIBs) received 37 per cent subscription. Anthem Biosciences has raised Rs 1,016 crore from anchor investors. The Rs 3,395-crore IPO of the Bengaluru-based firm will close on July 16. The price band has been fixed at Rs 540-570 per share. Since the IPO is entirely an offer-for-sale (OFS), the company will not receive any funds from the issue, and the proceeds will go to the selling shareholders. Anthem is into innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operat
    Copy LinkShare onShare on Share on Share on
    Anthem Biosciences Ltd. is trading below all available SMAs
    logo
    Neuland Laboratories Ltd.
    14 Jul 2025
    CEO Appointment Insider Trades
    14945.00
    -0.52%
    Neuland Laboratories shares jump 12% ahead of final dividend
    Neuland Laboratories shares jump 12% ahead of final dividend
    Economic Times
    Neuland Laboratories shares are experiencing a surge, trading 12% higher. This increase comes as investors anticipate a final dividend of Rs 12 per share. The record date for dividend eligibility is July 18, 2025. Technically, the stock shows a strong bullish trend. It trades above all analyzed Simple Moving Averages. The Relative Strength Index indicates neither oversold nor overbought conditions.
    Copy LinkShare onShare on Share on Share on
    Neuland Laboratories Ltd. is trading above all available SMAs
    Mukul Agrawal portfolio pharmaceutical stock surges 10% in weak market
    Business Standard | 14 Jul 2025
    more
    loading
    Trendlyne Logo Trendlyne
    Stay ahead of the market
    Markets Today
    • Nifty 50 today
    • Sensex today
    • Latest Quarterly results
    • FII & DII data today
    Dashboard
    • Industry & Sector analysis
    • ETFs
    • Mutual Funds
    • Bullish & Bearish spread
    • Global Indices
    Tools
    • Compare stocks
    • Widgets
    • Data Downloader
    • Excel Connect
    IPOs
    • Dashboard (Mainboard & SME)
    • Upcoming IPOs
    • Recently Listed IPOs
    • Most Successful IPOs
    Upcoming IPOs
    • True Colors
    • Aptus Pharma
    • Solarworld Energy Solutions
    Quick Links
    • Contact us
    • Blogs
    • FAQs
    Company
    • Privacy
    • Terms of Use
    • Disclaimer
    Trendlyne Products
    • Starfolio
    • SmartOptions
    • Trendlyne US Global
    Get Mobile App
    • Android
    • iOS

    Copyright © 2025 Giskard Datatech Pvt Ltd